Mike Snyder and colleagues are developing an at-home blood-testing process based on tiny samples and standard laboratory methods. The team is patenting its microsampling approach and has launched two companies, including iollo, to commercialize consumer metabolic tests that use the process.
Stanford researchers led by Michael Snyder report a microsampling approach that measures thousands of molecules from about 10 microliters of blood, a fraction of a typical clinical draw. Snyder has launched two companies based on the work, including iollo, which plans to provide wellness profiles from blood metabolites.
Stanford geneticist Michael Snyder studies microsampled blood and finds that a finger-prick drop can provide nearly the same results as a typical blood draw. The approach could support at-home monitoring, and Snyder has turned the research into companies including iollo, a metabolic testing startup.
iollo launches a subscription service that measures more than 500 molecules in users’ blood. The service uses those measurements to provide personalized action plans for diet and behavior, as well as future therapeutics, aiming to help users live healthier and much longer.